Board approves unaudited Q2 and H1 FY2025-26 results for the quarter and half-year ended September 30, 2025, with an accompanying Limited Review Report from the independent auditors.
AI Assistant
Vaishali Pharma Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.